Skip to main content
MNKD
NASDAQ Life Sciences

Breakthrough T1D Awards Grant to MannKind for Afrezza Pediatric Trial Advancement

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$3.831
Mkt Cap
$1.202B
52W Low
$2.23
52W High
$6.51
52W Position info
72% above low
Off High info
41% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

MNKD sits 72% above its 52-week low of $2.23.

Summary

MannKind has been awarded a grant from Breakthrough T1D (formerly JDRF) to support its INHALE-1ST clinical study, which is evaluating Afrezza in youth newly diagnosed with Type 1 Diabetes. This grant provides external validation and non-dilutive funding for a key pediatric trial. It builds on the recent FDA approval of Afrezza for pediatric use, underscoring the potential for the inhaled insulin in a significant new market segment. This support helps de-risk the trial and highlights Afrezza's role in addressing unmet needs in pediatric diabetes care.

At the time of this announcement, MNKD was trading at $3.83 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $2.23 to $6.51. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

MNKD - Latest Insights

MNKD
Nov 05, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.79
Real-time Price: $3.88 info
Change: +$0.085 (+2%) info
Market Cap: $1.24B info
MNKD
Nov 05, 2026, 4:01 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $3.76
Real-time Price: $3.88 info
Change: +$0.115 (+3%) info
Market Cap: $1.24B info
MNKD
Sep 09, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.28
Real-time Price: $3.88 info
Change: -$0.405 (-9%) info
Market Cap: $1.24B info
MNKD
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $4.12
Real-time Price: $3.88 info
Change: -$0.245 (-6%) info
Market Cap: $1.24B info
MNKD
Jul 29, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.03
Real-time Price: $3.88 info
Change: -$0.155 (-4%) info
Market Cap: $1.24B info